Clinical Trials on Bone Sarcoma

Total 28267 results

K-Group, Beta, Inc., a wholly owned subsidiary...

Active, not recruiting

A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma

Osteosarcoma

United States, France
Davidzon, Guido, M.D.

Terminated

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Osteosarcoma

United States
Eisai Inc.
Merck Sharp & Dohme LLC

Completed

A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

Osteosarcoma

Korea, Republic of, New Zealand, Spain, United States, Sweden, Taiwan, Singapore, Hong Kong, United Kingdom, France, Belgium, Switzerland, Australia, Ireland, Canada, Israel, Italy, Austria, Czechia, Finland, Netherlands
Memorial Sloan Kettering Cancer Center
Columbia University; Weill Medical College of Cornell University; Hospital for... and other collaborators

Active, not recruiting

Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors

Osteosarcoma

United States
Grupo Espanol de Investigacion en Sarcomas

Completed

ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities

Osteosarcoma

Spain
Isofol Medical AB

Completed

Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Osteosarcoma

Poland, Czechia, Hungary, Sweden
Centre Leon Berard

Completed

Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma (OSII-TTP)

Osteosarcoma

France
Fundació Institut de Recerca de l'Hospital de la...

Completed

Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and Survival

Osteosarcoma

Spain
Washington University School of Medicine

Terminated

Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy

Sarcoma | Osteosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy Volunteers

Sarcoma
Memorial Sloan Kettering Cancer Center

Completed

Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

Osteosarcoma

United States
Tianjin Medical University Cancer Institute and...

Unknown

A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy

Osteosarcoma
Shandong Simcere-Medgenn Bio-pharmaceutical Co....

Unknown

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Osteosarcoma

China
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Sarcoma

Canada, United States, Australia, Puerto Rico
Italian Sarcoma Group

Completed

Sorafenib in Relapsed High Grade Osteosarcoma

Osteosarcoma

Italy
National Cancer Institute (NCI)

Completed

Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study

Osteosarcoma

United States
Bambino Gesù Hospital and Research Institute

Recruiting

Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors

Sarcoma | Osteosarcoma | Ewing Sarcoma | Neuroblastoma | Neuroblastoma Recurrent | GD2-positive Solid Tumors

Italy
Istituto Ortopedico Rizzoli

Recruiting

An Observational Study of Local Relapse After High Grade Osteosarcoma (OSTEO LR)

Osteosarcoma

Italy
AlaMab Therapeutics (Shanghai) Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma

Osteosarcoma
Lee's Pharmaceutical Limited

Recruiting

A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma

Osteosarcoma

China
UNICANCER
Novartis; National Cancer Institute, France; Chugai Pharmaceutical; Ligue contre... and other collaborators

Active, not recruiting

Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma (OS2006)

Sarcoma

France
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors

Osteosarcoma

United States, Canada, Puerto Rico
Memorial Sloan Kettering Cancer Center

Available

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Osteosarcoma

United States
The Hospital for Sick Children

Completed

Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma

Osteosarcoma

Canada
Oslo University Hospital
Merck Sharp & Dohme LLC; Italian Sarcoma Group

Terminated

A Study of Pembrolizumab in Patients With Relapsed Or Metastatic Osteosarcoma Not Eligible for Curative Surgery (PROMO)

Osteosarcoma

Norway, Italy
University Hospital Heidelberg
Dietmar Hopp Stiftung

Completed

Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma

Osteosarcoma

Germany
Isofol Medical AB

Completed

A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX (FORTO)

Osteosarcoma

Norway, Sweden, Hungary, Poland
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Sarcoma

United States
M.D. Anderson Cancer Center
Schering-Plough

Completed

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

Osteosarcoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction

Osteosarcoma

United States
Tata Memorial Hospital
Pharmanza Herbals Pvt Limited (PHPL)

Unknown

Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma (OSCAT)

Osteosarcoma

India
Tata Memorial Hospital

Unknown

Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma (ZOL)

Osteosarcoma

India
Seoul National University Hospital
Samsung Medical Center; Asan Medical Center; Seoul National University Bundang... and other collaborators

Terminated

Pazopanib for Metastatic Alveolar Soft Part Sarcoma

Metastatic Alveolar Soft Part Sarcoma

Korea, Republic of
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Recurrent Ewing Sarcoma | Recurrent Childhood Rhabdomyosarcoma | Previously Treated Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Peripheral Primitive Neuroectodermal Tumor

United States, Canada
Centre Leon Berard

Recruiting

MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma (COTESARC)

Sarcoma,Soft Tissue

France
Xiangya Hospital of Central South University

Active, not recruiting

Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma

Sarcoma, Soft Tissue

China
Istituto Ortopedico Rizzoli

Completed

Analysis of the Molecular Profile of the Mixofibrosarcoma of the Extremities (MFS)

Sarcoma,Soft Tissue

Italy
Fox Chase Cancer Center

Terminated

Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

Soft-tissue Sarcoma

United States
Eisai Co., Ltd.

Completed

A Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas (HAL03T)

Sarcoma, Soft Tissue

Japan
Eli Lilly and Company

Completed

A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
Italian Sarcoma Group

Completed

Retrospective Study of Trabectedin in Soft Tissue Sarcomas (TrObs)

Sarcoma, Soft Tissue

Italy
Institut de Cancérologie de Lorraine

Completed

A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas

Sarcoma,Soft Tissue
University of Michigan Rogel Cancer Center

Completed

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
GlaxoSmithKline

Completed

Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy (PALETTE)

Sarcoma, Soft Tissue

United States, Australia, Germany, Spain, Belgium, Sweden, France, Korea, Republic of, Italy, Netherlands, Japan, United Kingdom, Denmark
Istituto Clinico Humanitas

Completed

BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas

Sarcoma, Soft Tissue

Italy
Assistance Publique - Hôpitaux de Paris

Unknown

Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma (KADIG 01)

Kaposi' s Sarcoma | Classic Kaposi' s Sarcoma | Endemic Kaposi' s Sarcoma | Lymph Angio Proliferations

France
National Cancer Institute (NCI)

Completed

Informed Consent in Pediatric Cancer Trials

Leukemia | Osteosarcoma | Neuroblastoma | Brain Tumors | Ewing's Sarcoma

United States
National Cancer Institute (NCI)
National Comprehensive Cancer Network

Completed

Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma

United States
National Cancer Institute (NCI)

Completed

Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma

United States
Italian Sarcoma Group

Terminated

Phase II Trial for the Treatment of Relapsed Osteosarcoma (OsteoREC2015)

OSTEOSARCOMA

Italy

Clinical Trials on Bone Sarcoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations